You are here

danuglipron

Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering

Fierce Biotech

Fri, 07/12/24 - 11:14 am

Viking Therapeutics

Terns Pharmaceuticals

Pfizer moves forward with once-daily version of weight loss pill after setbacks

CNBC

Thu, 07/11/24 - 11:57 am

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

Motley Fool

Sun, 05/5/24 - 11:40 pm

Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans

Fierce Biotech

Wed, 05/1/24 - 11:14 pm

Pfizer cans twice-daily oral obesity program after half of patients leave trial while once daily continues

Fierce Biotech

Fri, 12/1/23 - 09:50 am

clinical trials

Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro

Stat

Thu, 10/26/23 - 11:24 am

Pfizer Just Canned One of Its Ozempic Killers. What's Next?

Motley Fool

Mon, 07/3/23 - 10:37 am

Obesity: Six trials to watch over the next 12 months

Clinical Trials Arena

Fri, 06/30/23 - 11:45 am

clinical trials

Innovent Biologics

Pfizer, citing safety concerns, scraps one of two obesity pill hopefuls

BioPharma Dive

Mon, 06/26/23 - 09:57 am

ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer

EP Vantage

Wed, 06/21/23 - 10:38 am

Could Pfizer Have an Ozempic Killer on the Way?

Motley Fool

Mon, 06/5/23 - 10:07 am

Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss

Investors Business Daily

Tue, 05/23/23 - 11:19 am

clinical trials

EASD 2022 – Pfizer’s oral GLP-1s struggle for a therapeutic window

EP Vantage

Fri, 09/23/22 - 10:34 am